Study looks at distribution of new cases of diabetes, density of specialists

October 23, 2019

In the last five years, the landscape of type 2 diabetes treatment has changed dramatically. Two new classes of drugs -- SGLT2 inhibitors and GLP-1 receptor agonists -- have been shown to prevent some of the most serious diabetes complications, including heart and kidney conditions, in patients. While primary care physicians treat the majority of patients with type 2 diabetes, many patients also seek out internal medicine specialists, including nephrologists, endocrinologists and cardiologists for care. To better understand the distribution of specialists in the U.S. who may be able to help care for the rising number of patients with diabetes, researchers from Brigham and Women's Hospital analyzed national data on the prevalence of diabetes and the number of internal medicine specialists in each U.S. state. They found that cardiologists were the highest represented specialists and conclude that they are well positioned to be integral members of a patient's care team. Their findings are published in JAMA Cardiology.

"While patients with diabetes traditionally seek care from endocrinologists and/or primary care physicians, these national data suggest that a broader network of clinicians, including cardiologists and nephrologists, may provide additional avenues for care delivery," said corresponding author Muthiah Vaduganathan, MD, MPH, a cardiologist at the Brigham. "This is especially important as the cardiovascular and renal risks associated with diabetes are becoming increasingly recognized, and as new strategies become available to modify disease course."

Vaduganathan and colleagues used 2016 data from the U.S. Centers for Disease Control and Prevention U.S. Diabetes Surveillance System to find the number of new diabetes cases in each state. They also gathered data on the number of practicing endocrinologists, cardiologists, and nephrologists in each U.S. state using 2016 Centers for Medicare and Medicaid Services physician and other supplier public files.

In 2016, 1.9 million U.S. adults were newly diagnosed with diabetes. Colorado had the lowest density of cases (6.2 percent) and Puerto Rico had the highest (13.7 percent). The density of specialists varied widely, but overall, cardiologists were the highest represented specialists and there was a lower ratio of patients with diabetes to cardiologists than to nephrologists or endocrinologists.

"For any patient seeing a specialist, it's important to ask how your diabetes may put you at risk and if there's anything that can be done to reduce risk," said lead author Ravi B. Patel, MD, a former internal medicine resident at the Brigham. Patel is now a clinical fellow in cardiovascular medicine at Northwestern University. "Diabetes is a systemic disease and should be treated as such, with many specialists as part of a team providing optimal care."
-end-
Patel is supported by National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL069771.Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (National Institutes of Health [NIH]/National Center for Advancing Translational Sciences award UL 1TR002541); serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, and Boehringer Ingelheim; and participates on clinical end point committees for studies sponsored by Novartis and the NIH.

Paper cited: Patel, R et al. "Implications of Specialist Density for Diabetes Care in the United States" JAMA Cardiology DOI:10.1001/jamacardio.2019.3796

Brigham and Women's Hospital

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.